3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
33
Uterine Cervical Neoplasms
29
Endometrial Neoplasms
23
Breast Neoplasms
11
Fallopian Tube Neoplasms
7
Vulvar Neoplasms
6
Uterine Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Colorectal Neoplasms, Hereditary Nonpolyposis
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Vaginal Neoplasms
4
Neoplasms
4
Uterine Cervical Dysplasia
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Pelvic Neoplasms
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Vomiting
2
Urinary Bladder Neoplasms
2
Sarcoma
2
Obesity
2
Nausea
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lymphedema
2
Leukemia
2
Kidney Neoplasms
2
Gynecologic Cancer
2
Interventions
Mitomycin
7
Hyperthermic Intraperitoneal Chemotherapy
5
Oxaliplatin
4
Doxorubicin
3
Cisplatin
3
Trastuzumab
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
tipifarnib
1
sodium thiosulfate
1
nilotinib
1
motexafin lutetium
1
irinotecan sucrosofate
1
entinostat
1
durvalumab
1
dehydroftorafur
1
Surveys and Questionnaires
1
Referral and Consultation
1
Quality of Life
1
Psychiatric Rehabilitation
1
Platinum
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Ondansetron
1
Nutritional Status
1
Molecular Diagnostic Techniques
1
Mitozytrex
1
Melphalan
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Appendiceal Neoplasms
×
Surveys and Questionnaires
×
Gynecologic
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled